The Journal of Precision Medicine
Niche digital publisher serving precision medicine professionals and advertisers.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- The Journal of Precision Medicine
- Entity type
- COMPANY
- Headquarters
- C/o 1637 Stelton Road B2 Piscataway, NJ 08854
- Market role
- Publisher & Media Owner
- Official website
- thejournalofprecisionmedicine.com
What The Journal of Precision Medicine does
The business functions as a vertical digital publisher monetising a specialised professional audience. It creates and distributes editorial content in precision medicine to attract healthcare and life sciences readers, then sells access to that audience through advertising inventory, sponsorships and integrated marketing placements to industry advertisers.
Category differentiation
This is a specialised healthcare publishing brand and advertising property, not a precision medicine software vendor, clinical tool or pharmaceutical company. It should be distinguished from broader scientific publishers such as Nature, Springer or MDPI by its narrower editorial focus.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
The Journal of Precision Medicine is a specialised digital publication focused on precision and personalised medicine. It publishes editorial content, research-oriented analysis and industry commentary aimed at healthcare and life sciences professionals, positioning itself as a content bridge between molecular research and clinical application. Commercially, the publication operates primarily as a niche B2B media property. It generates revenue from advertising placements, sponsorships and related media exposure sold to pharmaceutical, biotech and healthcare marketers seeking access to a targeted professional audience. The asset is part of the Crain Communications portfolio following Crain's acquisition of Kneed Media, the publication's former parent.
Business model & monetisation
The company primarily uses an ad-supported publishing model. Revenue comes from B2B advertising placements, sponsored content and sponsorship packages sold against a niche healthcare audience, with no clear evidence of a paid subscription model or reader paywall.
- Digital advertising placements
- Ad-supported niche publisher inventory sold to healthcare and life sciences advertisers
- Sponsorships and integrated content packages
- Service fee / sponsorship revenue from branded exposure within the publication ecosystem
- Other portfolio-led commercial packages
- Cross-property or custom media solutions under parent ownership
Products & capabilities
No products with linked sources are available in this view.
Products & market categories
Media Channel
Technology
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
No sufficiently sourced and dated signals are available for this view.
Explore company relationships
Questions about The Journal of Precision Medicine
What is The Journal of Precision Medicine?
It is a specialised digital publication covering precision and personalised medicine for healthcare and life sciences audiences.
Who uses The Journal of Precision Medicine?
Healthcare professionals and researchers consume the content, while pharmaceutical, biotech and healthcare marketers buy advertising and sponsorship access.
How does The Journal of Precision Medicine make money?
It primarily earns revenue through advertising placements, sponsorships and related media packages sold to industry advertisers.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
10 publicly documented primary sources and citations linked across the market graph.
Continue your research on The Journal of Precision Medicine
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.